Latest filing published 24 Oct 2017 for ENTELLUS MEDICAL INC, €2,616.
Filing timeline
BuySaleInsider track record
Kevin L. Mensink: trading record in brief
Kevin L. Mensink discloses dealings in Entellus Medical Inc to SEC (Form 4). The record holds 8 filings, for trades running from 29 October 2015 to 20 October 2017.
Every open-market trade on record is a sale: 4 sales worth €454k. Besides market trades, the filings include 1 share grant and 3 option exercises. In 2017 alone, the filings show no purchases and 2 sales.
Most recently, on 24 October 2017, the filings show an option exercise worth €2,616 in Entellus Medical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kevin L. Mensink
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$1.240.6% of flowCommon Stock, $0.001 par valueSEC:0001235802-17-000161:0
- 2,500 shares@ US$19.008.6% of flowCommon Stock, $0.001 par valueSEC:0001235802-17-000161:1
- 10,000 shares@ US$1.242.2% of flowCommon Stock, $0.001 par valueSEC:0001235802-17-000160:0
- 10,000 shares@ US$18.2933.2% of flowCommon Stock, $0.001 par valueSEC:0001235802-17-000160:1
- 7,500 shares0Common Stock, $0.001 par valueSEC:0001235802-17-000005:0
- 8,000 shares@ US$18.3928.1% of flowCommon Stock, $0.001 par valueSEC:0001235802-16-000296:0
- 8,100 shares@ US$17.6327.4% of flowCommon Stock, $0.001 par valueSEC:0001235802-16-000292:0
- 16,100 shares@ US$1.24Common StockSEC:0001209191-15-077475:0
8 of 8 declarations
